5World Health Organization. Global strategy for containment of antimicrobial resistance. WHO/CDS/CSR/DRS, 2001, 2: 4-108.
6Reeves DS. Antimicrobial resistance surveillance: current initiatives are not enough. J Antimicrob Chemother, 2002,49:1.
7Centers for Diseases Control. Updated guidelines for evaluating public health surveillance systems. MMWR, 2001, 50: 1-35.
8Masterton RG. Surveillance studies:how can they help the management of infection? J Antimicrob Chemother, 2000,46:53-58.
二级参考文献6
1Barry AL, Thornsberry C. Susceptibility tests: diffusion test procedures.In: Murray P R, Baron E J, Pfalier MA. et al. Mannual of Clinical microbiology, 7th ed. American Society for Microbiology, 1999, 978-989.
2Andrews JM. For the BSAC working party on susceptibility testing.BSAC standardized disc susceptibility testing method. J Antimicrob Chemother, 2001, 48 (Suppl) 1: 43-57.
3King A, Brown DFJ. Quality assurance of antimicrobial susceptibility testing by disc diffusion. J Antimicrob Chemother, 2001, 48 (Suppl)S1: 71-76.
4National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility tests 7th edition: Approved Standard M2-A7: National Committee for Clinical Laboratory Standards,Wayne, pa, 2000.1.
5Tenover FC, Mohammed MJ, Stelling J, et al. Ability of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization' s external quality assurance system for antimicrobial susceptibility testing. J Clin Microbiol, 2001,39:241-250.
6National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility tests 12th edition informational supplement, M2-A.2001,1.
